Brad McCaw is currently the Associate Director of Market Access at Alexion Pharma, a Global leader in research and manufacturing of Life saving Rare Disease medications. Brad has over 25 years of experience within the specialty Biopharmaceutical sector with extensive experience in Sales Management, Marketing, Hospital Procurement and Market Access within the Private Insurance industry.
Brad is a multiple Global Excellence award recipient for successfully creating innovative healthcare initiatives that have led to improvements in patient’s health outcomes and positive healthcare system change. A rare disease industry thought leader and system change engineer, Brad has a passion for improving the healthcare ecosystem that focuses on improving access for devastating rare disease illnesses while focusing on drug plan sustainability.
Day 1: Oct 6, 2020
Day 2: Oct 7, 2020
Elevate Your Submission Strategy for PLA’s with Private Payers
Continued tightening of access to private payor formularies combined with a move to outsource benefit plan and administration to third parties for some payers, means more barriers to access this market than before. Hone your private payor access strategy by understanding new market developments and payor priorities. Create an action plan to:
- Leverage elements of successful public PLA submissions and adapt them for the private payer market
- Analyze the influence of public payer decisions on private payors to increase your preparedness
- What pharma companies can do to optimize the ROI of their submissions to private payers
Gain insight into what private payers need and succeed with a tailored approach to securing a PLA
Day 3: Oct 8, 2020